- Home
- IINN vs ATHA Comparison
IINN vs ATHA Comparison
Compare IINN & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IINN | ATHA |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.3M | 18.2M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IINN | ATHA |
|---|---|---|
| Price | $0.92 | $6.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | 142.0K | ★ 3.2M |
| Earning Date | 10-01-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $289,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,582.74 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.40 | $2.20 |
| 52 Week High | $1.65 | $8.36 |
Technical Indicators
Market Signals| Indicator | IINN | ATHA |
|---|---|---|
| Relative Strength Index (RSI) | 37.59 | 65.04 |
| Support Level | $0.88 | $7.00 |
| Resistance Level | $1.02 | $7.64 |
| Average True Range (ATR) | 0.06 | 0.64 |
| MACD | -0.02 | 0.16 |
| Stochastic Oscillator | 13.43 | 69.74 |
Price Performance
Historical ComparisonAbout IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.